MTCH2 expression was significantly associated with AD status, where expression levels were lower in AD cases compared with controls (p = 2.2x10-12 and 2.9x10-12; Table 6; Bonferroni p = 5x10-4). Here, MTCH2 is linked to Alzheimer disease.